Symvivo
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8900 Glenlyon Pkwy, Burnaby, British Col...Phone Number
(604) 428-7474Website
www.symvivo.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Symvivo
Symvivo, founded in 2013 and headquartered in Burnaby, Canada, is a clinical-stage gene therapy company developing oral DNA vaccines for life-threatening diseases, such as COVID-19, with broader therapeutic potential for IV therapeutics in cancer and genetic diseases.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Symvivo your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if Symvivo has recently received funding, and reach out quickly before it becomes old news!
Symvivo, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Symvivo has new funding data
Click to see if Symvivo had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Symvivo
Earning: See what the market has to say on Symvivo recently announced quarterly report
Product Launch: Get notified when Symvivo launches new products
Check out if Symvivo is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Symvivo as Masked Content
Find 3 more new buyers
Compare Similar Companies to Symvivo
Compare insights from companies similar to Symvivo, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Symvivo
<$5M
11-50
Private
<$5M
2013
N/A
Company Profile Activity
Activity Insights
Symvivo is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Symvivo is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Symvivo.
Symvivo financials insights
Gather financial insights about Symvivo, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Grant
$2.8M
2022
Grant
$650K
Symvivo Tech Stack
A closer look at the technologies used by Symvivo
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Symvivo
Sign Up For FreeTo access detailed company insights
Symvivo, founded in 2013 and headquartered in Burnaby, Canada, is a clinical-stage gene therapy company developing oral DNA vaccines for life-threatening diseases, such as COVID-19, with broader therapeutic potential for IV therapeutics in cancer and genetic diseases.... Read More
